Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.

Wilson A, Patel V, Chande N, Ponich T, Urquhart B, Asher L, Choi Y, Tirona R, Kim RB, Gregor JC.

Aliment Pharmacol Ther. 2013 Feb;37(3):340-5. doi: 10.1111/apt.12161. Epub 2012 Nov 28.

2.

Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.

Kurnik D, Loebstein R, Fishbein E, Almog S, Halkin H, Bar-Meir S, Chowers Y.

Aliment Pharmacol Ther. 2003 Jul 1;18(1):57-63.

3.

A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.

Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D.

J Rheumatol. 1993 Nov;20(11):1845-9.

PMID:
8308768
5.

Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.

Turner D, Doveh E, Cohen A, Wilson ML, Grossman AB, Rosh JR, Lu Y, Bousvaros A, Deslandres C, Noble A, Baldassano RN, Levine A, Lerner A, Wilson DC, Griffiths AM.

Gut. 2015 Dec;64(12):1898-904. doi: 10.1136/gutjnl-2014-307964. Epub 2014 Nov 21.

PMID:
25416066
6.

Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.

Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.

J Rheumatol. 2006 Mar;33(3):481-5. Epub 2006 Jan 15.

PMID:
16463431
7.

A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.

Nathan DM, Iser JH, Gibson PR.

J Gastroenterol Hepatol. 2008 Jun;23(6):954-8. Epub 2007 Jun 7.

PMID:
17559377
8.

Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.

Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.

J Rheumatol. 2004 Apr;31(4):645-8.

PMID:
15088287
9.

A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.

Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.

J Eur Acad Dermatol Venereol. 2008 Jan;22(1):19-24. Epub 2007 Nov 19.

PMID:
18031504
10.

Influence of food on the bioavailability of oral methotrexate in children.

Dupuis LL, Koren G, Silverman ED, Laxer RM.

J Rheumatol. 1995 Aug;22(8):1570-3.

PMID:
7473485
11.

Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.

Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS.

Clin Ther. 2009 May;31(5):1037-45. doi: 10.1016/j.clinthera.2009.05.001.

PMID:
19539104
12.
13.

Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.

van Dijkhuizen EH, Pouw JN, Scheuern A, Hügle B, Hardt S, Ganser G, Kümmerle-Deschner JB, Horneff G, Holzinger D, Bulatović Ćalasan M, Wulffraat NM.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):148-54. Epub 2016 Feb 2.

PMID:
26843067
14.

Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.

Tuková J, Chládek J, Nemcová D, Chládková J, Dolezalová P.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1047-53.

PMID:
20149329
15.

A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease.

Chande N, Ponich T, Gregor J.

Can J Gastroenterol. 2005 Sep;19(9):553-8.

PMID:
16151547
16.

Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.

Chládek J, Grim J, Martínková J, Simková M, Vanìèková J, Koudelková V, Noièková M.

Br J Clin Pharmacol. 2002 Aug;54(2):147-56.

17.

Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.

Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.

J Clin Gastroenterol. 2008 Apr;42(4):395-9. doi: 10.1097/MCG.0b013e31802e6875.

PMID:
18277899
18.

A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.

Hobl EL, Mader RM, Jilma B, Duhm B, Mustak M, Bröll H, Högger P, Erlacher L.

Clin Ther. 2012 May;34(5):1195-203. doi: 10.1016/j.clinthera.2012.03.059. Epub 2012 Apr 18.

PMID:
22516039
19.

Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.

Carmichael SJ, Beal J, Day RO, Tett SE.

J Rheumatol. 2002 Oct;29(10):2077-83.

PMID:
12375315
20.

Supplemental Content

Support Center